Cheng-Qi Fan, Jian-Min Yue / Bioorg. Med. Chem. 11 (2003) 703–708
707
respectively, and the aqueous part was condensed to
give water-soluble fraction W (122 g).
(37); EI-MS m/z (%): 376 [M–glc]+(25), 153 (36), 137
(100) and 124 (34); 1H and 13C NMR data: see Table 2.
The fraction Bu (45 g) was subjected to column chro-
matography (CC) on MCI GEL CHP 20P eluted with
H2O, 20% and 50% methanol in water, MeOH and
acetone to give fractions 1–5. Fraction 5 was passed
through a column of Sephadex LH-20 eluted with
EtOH to give daucosterol. Fraction 4 was re-chromato-
graphed on MCI GEL CHP 20P eluted with 70%
methanol in water to give a major fraction 4a contain-
ing flavonoids and four other fractions 4b–4e. Fraction
4d was then subjected to CC on silica gel eluted with
CHCl3–MeOH (10:1) to give compound 4 (18 mg).
Fraction 4a was subjected to CC on silica gel eluted
with petroleum ether–EtOAc–formic acid (2:1:0.02) to
give three parts and then passed through columns of
Sephadex LH-20 eluted with EtOH to give compounds
5 (75 mg), 7 (134 mg) and 8 (55 mg). Fraction 4c was
chromatographed on a reversed phase C18 silica gel
eluted with 80% methanol in water to give compound
16 (83 mg). Part of fraction 3 was passed through a
column of Sephadex LH-20 eluted with 70% ethanol in
water to give two flavonoid glycosides, compound 6
(784 mg) and 9 (51 mg). Fraction 2 was re-chromato-
graphed on a column of MCI GEL CHP 20P eluted
with 10–50% methanol in water to obtain six fractions
2a–2f. Compounds 12 (13.5 mg) and 13 (6.5 mg) were
obtained from fraction 2a by extensive column chro-
matography on reversed phase C18 silica gel eluted with
30–40% methanol in water. Fraction 2bwas passed
through a column of Sephadex LH-20 eluted with 70%
ethanol in water and then subjected to CC on silica gel
eluted with CHCl3–MeOH (6:1) to give compound 15
(16 mg). Fraction 2c was subjected to CC on silica gel
eluted with CHCl3–MeOH (6:1) to give compound 14
(68 mg). Fraction 2d was passed through a column of
Sephadex LH-20 eluted with 70% ethanol in water and
then re-chromatographed on reversed phase C18 silica gel
eluted with 40% methanol in water to give compounds 1
(15 mg) and 2 (12.5 mg). Fraction 2e was chromato-
graphed on reversed phase C18 silica gel eluted with 40%
methanol in water to give compound 3 (13 mg).
Acidic hydrolysis of 2. Compound 2 (6 mg) was added
to 4 mL 5% H2SO4 in MeOH and refluxed for 4 h. The
reaction mixture was neutralized with 5% NaHCO3 and
then worked up to give yellow residue. The residue was
passed through a Sephadex LH-20 column eluted with
EtOH to obtain glucose and (À)-berchemol (3.2 mg)
which was identified by comparison of co-TLC and
optical rotation [a]D20 À9.3ꢀ (c 0.081, MeOH) with those
of authentic sample.
Apigenin 7-O-[ꢀ-L-rhamnopyranosyl-(1!6)-ꢁ-D-gluco-
pyranoside] (6). Yellow amorphous power. Positive
ESI-MS m/z (%): 601.3 [M+Na]+ (100), 579.3
[M+H]+ (80), 433.3 [M+H-146]+ (47), 271.5 [M+H-
146-162]+ (66); 1H NMR data (400 MHz, DMSO-d6) d:
6.87 (1H, s, H-3), 6.45 (1H, s, H-6), 6.78 (1H, s, H-8),
6.98 (2H, d, J=8.8 Hz, H-30, 50), 7.98 (2H, d, J=8.8 Hz,
H-20, 60), 5.08 (1H, d, J=7.3 Hz, glc-1), 4.54 (1H, s,
rhm-1), 1.08 (1H, s, rhm-6); 13C NMR data (100 MHz,
DMSO-d6) d: 164.4 (C-2), 103.1 (C-3), 182.0 (C-4),
105.4 (C-4a), 161.2 (C-5), 99.9 (C-6), 162.9 (C-7), 94.8
(C-8), 157.0 (C-8a), 121.1 (C-10), 128.7 (C-20, 60), 161.2
(C-40), 116.1 (C-30, 50), 99.5 (glc-1), 72.0 (glc-2), 76.2
(glc-3), 70.7 (glc-4), 75.6 (glc-5), 66.0 (glc-6), 100.5 (rhm-
1), 70.3 (rhm-2), 69.5 (rhm-3), 73.1 (rhm-4), 68.3 (rhm-
5) and 17.8 (rhm-6).
2-(4-Hydroxy-3-methoxyphenyl)ethyl ꢁ-D-glucopyrano-
side (11). White amorphous powder. Positive ESI-MS
m/z (%): 353.3.2 [M+Na]+ (100); negative ESI-MS m/z
(%): 329.3 [M–H]À (100), 167.1 [M–H-162]À (30), 113.0
1
(95); H NMR data (400 MHz, CD3OD) d: 3.55, 3.90
(2H, m, H-1), 2.67 (2H, m, H-2), 6.70 (1H, d, J=1.8 Hz,
H-20), 6.53 (1H, d, J=8.0 Hz, H-50), 6.49 (1H, dd,
J=1.8, 8.0 Hz, H-60), 3.66 (3H, s, H-OMe), 4.13 (1H, d,
J=7.7 Hz, glc-1), 3.00-3.18 (4H, m, glc-2, 3, 4, 5), 3.50,
3.70 (2H, m, glc-6); 13C NMR data (100 MHz, CD3OD)
d: 72.0 (C-1), 36.7 (C-2), 131.6 (C-10), 113.8 (C-20), 148.8
(C-30), 145.9 (C-40), 116.1 (C-50), 122.4 (C-60), 56.4 (C-
OMe), 104.3 (glc-1), 75.1 (glc-2), 78.1 (glc-3), 71.7 (glc-
4), 77.9 (glc-5), 62.8(glc-6).
Medusaside
A
(1). White amorphous powder.
[a]2D0 À 60:9ꢀ (c 0.755, MeOH); UV lmax (MeOH) (log
"): 229 (4.08), 279 (3.85), 306 (3.68) nm; IR (KBr disc)
ꢀ=3406 (OH), 2933 (C–H), 1655, 1591, 1516 (Ar–
C¼O), 1450, 1427 (C–H), 1275, 1161, 1076, 1031 (C–O)
cmÀ1; positive ESI-MS m/z (%): 561.3 [M+Na]+ (100);
negative ESI-MS m/z (%): 537.2 [M–H]À (100); EI–MS
m/z (%): 376 [M–glc]+(5), 358 [M–glc–H2O]+(8), 340
[M–glc–2H2O]+(12), 191 (20), 151 (48), 137 (100) and
Biology
Effects on scopolamine-induced memory deficits of mice.
Effects on scopolamine-induced memory deficits of mice
were carried out according to the procedure described in
the literature.16
Tests of cell protective activities. Evaluation of cell pro-
tective activities of major phenols against H2O2-iduced
PC12 cell damage was made according to the protocol
reported in the literatures.17
1
98 (88); H and 13C NMR data: see Table 1.
Medusaside B (2). White amorphous powder. [a]D20
À34.9ꢀ (c 0.53, MeOH); UV lmax (MeOH) (log "): 227
(3.89), 279 (3.43) nm; IR (KBr disc) ꢀ=3415 (OH), 2924
(C–H), 1601, 1514 (Ar), 1452, 1425 (C–H), 1269, 1070,
1032 (C–O) cmÀ1; Positive ion mode ESI-MS m/z (%):
561.2 [M+Na]+ (48), 399.1 [M+Na-162]+ (100);
Negative ion mode ESI-MS m/z (%): 537.3 [M–H]À (23),
489.0 (25), 374.9 [M–H-162]À (100), 345.0 (20) and 327.0
Acknowledgements
Financial support of the National Scientific Foundation
(for J. M. Yue, 30025044) and the Shanghai Municipal
Scientific Foundation for Fundamental Research (for J.